Navigation Links
Electrochemistry controlled with a plasma electrode

Engineers at Case Western Reserve University have made an electrochemical cell that uses a plasma for an electrode, instead of solid pieces of metal.

The technology may open new pathways for battery and fuel cell design and manufacturing, making hydrogen fuel and synthesizing nanomaterials and polymers.

A description of the research is now published in the online edition of the Journal of the American Chemical Society at

"Plasmas formed at ambient conditions are normally sparks which are uncontrolled, unstable and destructive," said Mohan Sankaran, a chemical engineering professor and senior author of the paper. "We've developed a plasma source that is stable at atmospheric pressure and room temperature which allows us to study and control the transfer of electrons across the interface of a plasma and an electrolyte solution."

Sankaran worked with former students Carolyn Richmonds and Brandon Bartling, current students Megan Witzke and Seung Whan Lee and fellow chemical engineering professors Jesse Wainright and Chung-Chiun Liu.

The group used a traditional set up with their nontraditional electrode.

They filled an electrochemical cell, essentially two glass jars joined with a glass tube, with an electrolyte solution of potassium ferricyanide and potassium chloride.

For the cathode, argon gas was pumped through a stainless steel tube that was placed a short distance above the solution. A microplasma formed between the tube and the surface.

The anode was a piece of silver/silver chloride.

When a current was passed through the plasma, electrons reduced ferricyanide to ferrocyanide.

Monitoring with ultraviolet-visible spectrophotometry showed the solution was reduced at a relatively constant rate and that each ferrycyanide molecule was reduced to one ferrocyanide molecule.

As the current was raised, the rate of reduction increased. And testing at both electrodes showed no current was lost.

The researchers, however, found two drawbacks.

Only about one in 20 electrons transferred from the plasma was involved in the reduction reaction. They speculate the lost electrons were converting hydrogen in the water to hydrogen molecules, or that other reactions they were unable to monitor were taking place. They are setting up new tests to find out.

Additionally, the power needed to form the plasma and induce the electrochemical reactions was substantially higher than that required to induce the reaction with metal cathodes.

The researchers know their first model may not be as efficient as what most industries need, but the technology has potential to be used in a number of ways.

Working with Sankaran, Seung has scanned a plasma over a thin film to reduce metal cations to crystalline metal nanoparticles in a pattern.

"The goal is to produce nanostructures at the same small scale as can be done now with lithography in a vacuum, but in an open room," Seung said.

They are investigating whether the plasma electrode can replace traditional electrodes where they've come up short, from converting hydrogen in water to hydrogen gas on a large scale to reducing carbon dioxide to useful fuels and commodity chemicals such as ethanol.

The researchers are fine-tuning the process and testing for optimal combinations of electrode design and chemical reactions for different uses.

"This is a basic idea," Sankaran said. "We don't know where it will go."


Contact: Kevin Mayhood
Case Western Reserve University

Related biology technology :

1. Building, Validating & Maintaining Controlled Environment Facilities is Focus of Oct. 18th Seminar in Boston Hosted by Microtest Laboratories
2. Mind-Controlled Bionic Limbs Holding Promise, and the Demand is Growing say IEEE Experts
3. Light propagation controlled in photonic chips -- major breakthrough in telecommunications field
4. UCLA researchers now 1 step closer to controlled engineering of nanocatalysts
5. Robot arm improves performance of brain-controlled device
6. Lotus Pharmaceuticals Announces New Patent for Controlled-Release Diabetes Drug
7. Phase III Randomised Controlled Trial Confirms Clinical Efficacy and Safety of Radioembolisation Using 90Y-resin Microspheres for Patients With Inoperable Colorectal Cancer Liver Metastases That Have Failed Chemotherapy
8. Health Robotics i.v.STATION Certified as the Only Robot to Comply with Security Guidelines for Controlled Substances
9. YM BioSciences announces controlled equity offering
10. Æterna Zentaris Partner Keryx Reports a Statistically Significant Benefit in Survival from Updated Results of a Randomized, Double-Blind, Placebo-Controlled Phase 2 Study of Perifosine (KRX-0401) in the Treatment of Advanced Metastatic Colon Cancer
11. Harvest Technologies Announces Completion of Patient Enrollment in its Randomized, Controlled, Double Blind Multicenter IDE Non-Reconstructable Critical Limb Ischemia Trial
Post Your Comments:
(Date:11/24/2015)... SAN DIEGO , Nov. 24, 2015 Halozyme Therapeutics, ... Jaffray Healthcare Conference in New York on ... Dr. Helen Torley , president and CEO, will provide a ... New York at 1:00 p.m. ET/10:00 a.m. ... communication and investor relations, will provide a corporate overview. --> ...
(Date:11/24/2015)... , ... November 24, 2015 , ... ... healthy metabolism. But unless it is bound to proteins, copper is also toxic ... (NIH), researchers at Worcester Polytechnic Institute (WPI) will conduct a systematic study of ...
(Date:11/24/2015)... , Nov. 24, 2015 /PRNewswire/ - Aeterna Zentaris Inc. ... IIROC on behalf of the Toronto Stock Exchange, confirms ... there are no corporate developments that would cause the ... --> --> About Aeterna Zentaris ... . --> Aeterna Zentaris is a specialty ...
(Date:11/24/2015)... PUNE, India , November 24, 2015 ... to a new market research report "Oligonucleotide Synthesis Market ... Equipment), Application (PCR, Gene Synthesis, Diagnostic, DNA, RNAi), End-User ... to 2020", published by MarketsandMarkets, the market is expected ... 1,078.1 Million in 2015, at a CAGR of 10.1% ...
Breaking Biology Technology:
(Date:11/17/2015)... , November 17, 2015 ... 19 novembre  2015.  --> Paris , ... --> DERMALOG, le leader de l,innovation biométrique, a ... fois passeports et empreintes sur la même surface de ... passeports et l,autre pour les empreintes digitales. Désormais, un ...
(Date:11/12/2015)... Nov. 12, 2015  A golden retriever that stayed ... dystrophy (DMD) has provided a new lead for treating ... the Broad Institute of MIT and Harvard and the ... . Cell, pinpoints a protective ... the disease,s effects. The Boston Children,s lab of ...
(Date:11/10/2015)... , Nov. 10, 2015  In this ... the basis of product, type, application, disease ... in this report are consumables, services, software. ... are safety biomarkers, efficacy biomarkers, and validation ... report are diagnostics development, drug discovery and ...
Breaking Biology News(10 mins):